Market Place
Sourcing Support
All News #Library
Biotech
Fulcrum to Present Ph1b Pociredir Data in SCD Disease
17 Feb 2026 //
GLOBENEWSWIRE
Fulcrum Therapeutics Discloses Inducement Grants Per Nasdaq Lr
06 Feb 2026 //
GLOBENEWSWIRE
Fulcrum Therapeutics Reports Inducement Grants Under Nasdaq Rules
09 Jan 2026 //
GLOBENEWSWIRE
Fulcrum Therapeutics Joins 44th J.P. Morgan Healthcare Conference
07 Jan 2026 //
GLOBENEWSWIRE
Fulcrum Pharma Prices $175M Stock Offering And Warrants
10 Dec 2025 //
GLOBENEWSWIRE
Fulcrum Therapeutics Reports Positive Phase 1B Pociredir Results
06 Dec 2025 //
GLOBENEWSWIRE
Fulcrum Therapeutics Discloses Inducement Grants Per Nasdaq LR
05 Dec 2025 //
GLOBENEWSWIRE
Fulcrum Reveal Ph 1b Results of Pociredir for Sickle Cell Disease
29 Jul 2025 //
GLOBENEWSWIRE
Fulcrum Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
07 Dec 2023 //
GLOBENEWSWIRE
Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.